Sacituzumab Govitecan 180 mg Injection significantly improves the quality of life for cancer patients by targeting the Trop-2 protein on tumor cells and delivering precise treatment. This approach minimizes side effects, enhancing patient outcomes and overall well-being. The availability of Sacituzumab Govitecan 180 mg in India ensures access to advanced care for those battling challenging cancers. Impomed Healthcare actively supports its distribution, making this therapy accessible to patients nationwide. For more information Visit:- https://www.impomedhealthcare.com/